A detailed history of New Edge Advisors, LLC transactions in Embecta Corp. stock. As of the latest transaction made, New Edge Advisors, LLC holds 360 shares of EMBC stock, worth $4,500. This represents 0.0% of its overall portfolio holdings.

Number of Shares
360
Previous 364 1.1%
Holding current value
$4,500
Previous $6,000 33.33%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$12.35 - $19.33 $49 - $77
-4 Reduced 1.1%
360 $4,000
Q4 2023

Feb 13, 2024

SELL
$12.87 - $19.09 $1,325 - $1,966
-103 Reduced 22.06%
364 $6,000
Q3 2023

Nov 14, 2023

SELL
$15.0 - $22.17 $990 - $1,463
-66 Reduced 12.38%
467 $7,000
Q2 2023

Aug 14, 2023

SELL
$21.6 - $30.69 $2,743 - $3,897
-127 Reduced 19.24%
533 $11,000
Q1 2023

May 12, 2023

SELL
$23.07 - $32.77 $7,613 - $10,814
-330 Reduced 33.33%
660 $18,000
Q4 2022

Feb 14, 2023

BUY
$25.29 - $35.48 $25,037 - $35,125
990 New
990 $25,000

Others Institutions Holding EMBC

About Embecta Corp.


  • Ticker EMBC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 57,836,500
  • Market Cap $723M
  • Description
  • Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...
More about EMBC
Track This Portfolio

Track New Edge Advisors, LLC Portfolio

Follow New Edge Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Edge Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Edge Advisors, LLC with notifications on news.